Attached files
| file | filename |
|---|---|
| EX-99.1 - NEWS RELEASE DATED JANUARY 27, 2015 - Cell MedX Corp. | ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 27, 2015
CELL MEDX CORP.
(Exact name of registrant as specified in its charter)
|
NEVADA
|
000-54500
|
38-3939625
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
4575 Dean Martin Drive, STE 2206
Las Vegas, NV
|
89103
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
Registrant's telephone number, including area code
|
(310) 508-9398
|
|
n/a
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
|
|
|
(17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1
|
ITEM 8.01 OTHER EVENTS.
|
On January 27, 2015, Cell MedX Corp. (the “Company”) issued a news release advising investors not to rely on reports on the Company published in The Moskowitz Report and the SmallCap Network. The Company has not approved, authorized or participated in the creation or distribution of any reports prepared by The Moskowitz Report, the SmallCap Network, or any other third parties.
A copy of the Company’s news release is attached as an exhibit to this report.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
The following exhibits are either provided with this Current Report or are incorporated herein by reference:
|
Exhibit Number
|
Description of Exhibit
|
|
99.1
|
News Release dated January 27, 2015.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CELL MEDX CORP. | |||
|
Date: January 27, 2015
|
By:
|
/s/ Frank McEnulty | |
| Name: Frank McEnulty, | |||
| Title: Chief Executive Officer | |||
2